New guidelines offer hope for fatigue management in people with inflammatory RMD

Rigorous measures need to be in place to protect clinical staff from toxic HPAPIs. Image credit: Gorodenkoff The demand for high-potency active pharmaceutical ingredients (HPAPIs)

Two of As­traZeneca’s top can­cer treat­ments have been ap­proved in com­bi­na­tion to treat a sub­group of en­dome­tri­al can­cer pa­tients in the Eu­ro­pean Union, the drug­mak­er